Session 1: Neuromodulation in Epilepsy
- 02:05 PM - 02:15 PM Chair overview. Session Chair: Esther Krook-Magnuson, Neuroscience, UMN
- 02:15 PM - 02:45 PM Ivan Soltesz, PhD, Stanford University, “Organization and control of hippocampal networks”
- 02:45 PM - 03:15 PM Patrick Forcelli, PhD, Georgetown University School of Medicine, "Modulation of subcortical choke points in seizure networks"
- 03:15 PM - 03:45 PM Martha Morrell, MD, Stanford University, CMO NeuroPace, "Brain Responsive Stimulation For Partial Onset Seizures: Data Driven Treatment "
- 03:45 PM - 04:05 PM Refreshments, visit with exhibitors
Session 2: Neuromodulation of the Autonomic Nervous System
- 04:05 PM - 04:15 PM Chair overview. Session Chair: John Osborn, UMN
- 04:15 PM - 04:45 PM Terry Powley, PhD, Purdue, "Modifying neuromodulation therapies for stomach disorders"
- 04:45 PM - 05:15 PM Stephen J. Lewis, PhD, Case Western Reserve University , "Modulation of neural activity of the superior cervical ganglion: Implications for health and disease"
- 05:15 PM - 05:45 PM Valentin Pavlov, PhD, Hofstra/Northwell, “Cholinergic modalities and bioelectronics for treating inflammation and metabolic derangements”
Grant Opportunities/Government Initiatives
- 06:05 PM - 07:20 PM Buffet dinner and cash bar
Voice of Community Partners (Patients, caregivers, and research participants reflect on their experience with neuralmodulation and where research can benefit them)
- 08:00 PM - 09:00 PM Patients: TBD
- 08:00 AM - 09:00 AM Continental breakfast, visit with exhibitors
Session 3: Neuromodulation in Pain and Addiction
- 09:00 AM - 09:10 AM Chair overview. Session Chairs: Mark Thomas, Neuroscience, UMN, and Alik Widge, Neurology, UMN
- 09:10 AM - 09:40 AM Allen W. Burton, MD, Abbott, “Burst Spinal Cord Stimulation: Neuroscience and Outcomes. Is this an Electrical Solution to the Opioid Epidemic?”
- 09:40 AM - 10:10 AM Colleen Hanlon, PhD, Medical University of South Carolina, “Saving Adam from the Apple: developing TMS as a non-invasive tool to resist temptation and decrease drug cue-reactivity”
- 10:10 AM - 10:40 AM Alik Widge, MD, PhD, Psychiatry, UMN, "Deep Brain Stimulation to Modify Circuits of Compulsive, Habitual Behavior"
- 12:00 PM - 01:00 PM Boxed lunches provided, visit with exhibitors
- 01:00 PM - 02:00 PM Chair: Tay Netoff, PhD, Dept. of Biomedical Engineering, Director, Center for Neuroengineering, UMN.
Panel:
Tom Tcheng, PhD, NeuroPace
Allen W. Burton, MD, Abbott Labs
Lothar Krinke, PhD, Magstim, West Virginia University
Jeff Kramer, PhD, Medtronic
Edward S. Andrle, LivaNova
Rafael Carbunaru, Ph.D. Boston Scientific
Session 4: Noninvasive Neuromodulation for Stroke
- 02:00 PM - 02:10 PM Chair overview. Session Chairs: Bernadette Gillick, Rehabilitation Medicine, UMN, and Alex Opitz, Biomedical Engineering, UMN
- 02:10 PM - 02:40 PM John Rothwell, PhD, University College London, "Can non-invasive neuromodulation ever be a practical option in stroke rehabilitation?"
- 02:40 PM - 03:10 PM Adam Kirton, MD, University of Calgary, "Stroke in the developing brain: Applications of neurostimulation"
- 03:10 PM - 03:40 PM Alvaro Pascual-Leone, MD, PhD, Neurology, Harvard BIDMC, "Perturbation biomarkers with noninvasive brain stimulation to assess brain health and detect disease"